Technology News and Research

RSS

BD third-quarter revenues increase 3.2% to $1.878 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.878 billion for the third fiscal quarter ended June 30, 2010, representing an increase of 3.2 percent from the prior-year period, or 3.9 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 29 Jul 2010

NARSAD to honor five young scientists at Annual Klerman and Freedman Awards event

July 30 NARSAD will honor five outstanding researchers at the Annual Klerman and Freedman Awards event in New York City.

29 Jul 2010

E-cigarette aerosol decreases over time in smoke-out interval, researchers find

Stronger suction is required to smoke "electronic cigarettes" - marketed as tobacco-free nicotine delivery systems - than conventional brands, with possible adverse effects on human health, researchers at the University of California, Riverside report.

29 Jul 2010

NCQA recognizes 51 primary care practice sites as Level 3 patient-centered medical homes

An innovative quality initiative in the Hudson Valley has resulted in National Committee for Quality Assurance Recognition of 51 primary care practice sites as Level 3 patient-centered medical homes, the highest level achievable. This groundbreaking accomplishment was achieved by 236 physicians within 11 primary care practice groups (7 medical groups with multiple practice locations and 4 single site practices) and represents 44 percent of total Level 3 clinicians in New York, and nearly 10 percent of all practices at this level across the country.

29 Jul 2010

Exact Sciences to demonstrate methylation specific technology at AACC annual meeting

Exact Sciences Corp. today announced that data being presented this afternoon at the annual meeting of the American Association of Clinical Chemistry demonstrates that its methylation specific technology, using a combination of DNA methylation markers, detected 100 percent of colorectal cancers and precancers at a specificity cutoff of 100 percent in a preliminary study with colorectal tissue.

29 Jul 2010

WIREC Director testifies on the implementation of HITECH Act

Peggy Evans, PhD, CPHIT, Director of the Washington & Idaho Regional Extension Center testified before the House Committee on Energy and Commerce, Subcommittee of Health, Tuesday, July 27, 2010, in Washington, DC. Dr. Evans joined David Blumenthal, MD, National Coordinator for Health Information Technology and several others on two panels of witnesses.

29 Jul 2010

ACT responds to FDA queries on Phase I/II study using ES cell derived retinal cells to treat SMD

Advanced Cell Technology, Inc. announced today that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).

29 Jul 2010

Research to help people born with 'face blindness'

A specific area in our brains is responsible for processing information about human and animal faces, both how we recognize them and how we interpret facial expressions. Now, Tel Aviv University research is exploring what makes this highly specialized part of the brain unique, a first step to finding practical applications for that information.

29 Jul 2010

Oxford Life Insurance releases new Medicare Supplement product portfolio

Oxford Life Insurance Company today announced the release of its new Medicare Supplement product portfolio. The Phoenix-based life insurance company has plans to market Plans A, C or F, and N in more than 35 states.

29 Jul 2010

IBM, UPMC partner to provide redesigned SmartRoom solution with service-oriented architecture

IBM and UPMC (University of Pittsburgh Medical Center) are teaming up to bring "smarter" hospital rooms to patients nationwide. Created by UPMC three years ago to bring the right patient information to the bedside when it's needed, the high-tech "smart room" now features new capabilities, namely a system for automatically organizing and prioritizing the work of nurses and other caregivers. Under a new agreement, IBM will be the exclusive sales channel for the SmartRoom solution and will help to implement the technology for customers.

29 Jul 2010

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

NDS Surgical Imaging (NDSsi) today launched its next-generation visualization and informatics platform—the ConnectOR G2—with production units now shipping to customers. Based on the NDSsi technology vision of Medical Visualization Informatics (MVI), ConnectOR G2 medical-grade products are leading the industry in procedural efficacy by offering the unique ability to connect the realms of PACS imaging, surgical video and medical informatics.

29 Jul 2010

China PharmaHub to close Merger Agreement with World Wide Relics in August 2010

China PharmaHub Corp., a pharmaceutical HUB between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, announced today that it has entered into a Merger Agreement with World Wide Relics, Inc.. The merger is expected to close in August 2010.

29 Jul 2010

Encision’s AEM system recognized as technology to eliminate visceral burns

Encision Inc, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, recognized as a technology to eliminate visceral burns during monopolar electrical surgery.

29 Jul 2010

Scientists study mutant protein lump formation process to control brain cell death

Australian scientists have identified the behaviour of the mutant protein 'huntingtin' which leads to the fatal Huntington's disease providing potential targets to treat the disease, a University of Melbourne study reveals.

29 Jul 2010

Humana collaborates with HealthCompare to facilitate online health insurance

Humana, one of the nation's leading health and supplemental benefits companies, has entered into an arrangement with HealthCompare,a one-stop online guide to help individuals and families easily research, compare, buy and enroll in a health insurance plan at the right price. While this arrangement is new for Humana and HealthCompare, it builds on both organizations' efforts to help consumers make healthcare decisions with confidence and success.

29 Jul 2010

Etubics enters Phase I trials for next generation vector vaccines

Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.

29 Jul 2010

Cerner second-quarter revenue increases 13% to $456.0 million

Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.

29 Jul 2010

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

29 Jul 2010

Anti-fraud efforts backed by AARP; Seniors cautioned about rebate cons

AARP on Tuesday "threw its influence" behind a number of plans to reduce Medicare fraud, including the bipartisan Medicare Fraud Enforcement and Prevention Act, which would increase penalties on nabbed fraudsters and supply more claims data to enforcers, The Hill reports. Separate legislation, "the Fighting Fraud with Innovative Technology Act, would bolster Medicare's claims screening process before payments are sent out" (Lillis, 7/27).

29 Jul 2010

HemoBioTech receives patent for HemoTech treatment of acute blood loss

HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.

29 Jul 2010

Technology News and Research

BD third-quarter revenues increase 3.2% to $1.878 billion

NARSAD to honor five young scientists at Annual Klerman and Freedman Awards event

E-cigarette aerosol decreases over time in smoke-out interval, researchers find

NCQA recognizes 51 primary care practice sites as Level 3 patient-centered medical homes

Exact Sciences to demonstrate methylation specific technology at AACC annual meeting

WIREC Director testifies on the implementation of HITECH Act

ACT responds to FDA queries on Phase I/II study using ES cell derived retinal cells to treat SMD

Research to help people born with 'face blindness'

Oxford Life Insurance releases new Medicare Supplement product portfolio

IBM, UPMC partner to provide redesigned SmartRoom solution with service-oriented architecture

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

China PharmaHub to close Merger Agreement with World Wide Relics in August 2010

Encision’s AEM system recognized as technology to eliminate visceral burns

Scientists study mutant protein lump formation process to control brain cell death

Humana collaborates with HealthCompare to facilitate online health insurance

Etubics enters Phase I trials for next generation vector vaccines

Cerner second-quarter revenue increases 13% to $456.0 million

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Anti-fraud efforts backed by AARP; Seniors cautioned about rebate cons

HemoBioTech receives patent for HemoTech treatment of acute blood loss

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News